{"id":62375,"date":"2025-12-17T22:05:54","date_gmt":"2025-12-17T21:05:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/"},"modified":"2025-12-17T22:05:54","modified_gmt":"2025-12-17T21:05:54","slug":"cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/","title":{"rendered":"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions"},"content":{"rendered":"<div>\n<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cosan, a connected chronic care management company helping providers extend care beyond the clinic, today announced a $15 million strategic growth equity investment led by Ziegler Link-age Funds and Specialty Alliance, the nation\u2019s largest provider of specialty care and a long-standing Cosan partner.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/4\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/22\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/4\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/21\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\"><\/a><\/p>\n<p>\nThe investment accelerates Cosan\u2019s expansion of its AI-enabled, human-led virtual care platform, which empowers providers to deliver proactive, compassionate, and personalized support to individuals living with chronic conditions in between office visits. The funding will advance Cosan\u2019s ability to scale its multidisciplinary care teams, enhance AI-driven insights, and support practices seeking to improve outcomes while strengthening operational efficiency.\n<\/p>\n<p>\n\u201cWe\u2019re proud to deepen our partnership with Cosan,\u201d said Katie Schmitz, Managing Partner at Ziegler Link-age Funds. \u201cCosan is demonstrating how AI can amplify the human touch\u2014closing care gaps, strengthening relationships, and delivering outcomes that matter to patients and providers.\u201d\n<\/p>\n<p>\nDr. Paul Berggreen, Chief Strategy Officer at Specialty Alliance, added: \u201cCosan has been an exceptional partner for supporting our patients between visits. As we broaden our services across GI, urology, rheumatology, and oncology, their chronic care management model remains an essential resource.\u201d\n<\/p>\n<p>\nCosan currently serves more than 130,000 patients nationwide and enrolls 300 new patients each day, helping practices expand chronic care programs without sacrificing empathy or clinical quality. Its AI tools synthesize patient data, surface rising risks, streamline workflows, and personalize engagement while allowing clinicians to stay focused on meaningful patient interactions.\n<\/p>\n<p>\n\u201cOur mission is to help providers deliver compassionate, high-quality care beyond the office,\u201d said David Hunt, CEO of Cosan. \u201cAI allows us to extend the reach of care teams, not replace them. This investment strengthens our ability to deliver connected, timely, and personal care that improves lives.\u201d\n<\/p>\n<p>\nCosan\u2019s approach supports the healthcare industry\u2019s shift toward proactive, value-based chronic disease management\u2014bringing together advanced automation with real human connection.\n<\/p>\n<p>\n<b>About Cosan<\/b>\n<\/p>\n<p>\nCosan connects care where it matters most\u2014between patients and the people who serve them. We bring compassion, continuity, and efficiency to chronic care management by helping providers extend their reach beyond the office. Our mission is to ensure care is not only managed, but personal, timely, and focused on improving every life we touch.\n<\/p>\n<p>\n<b>About Ziegler Link-age Funds<\/b>\n<\/p>\n<p>\nZiegler Link-age Funds invest in companies transforming aging services, healthcare delivery, and health technology. A joint venture between Ziegler and Link-age, the funds unite innovators and providers committed to improving the lives of older adults and their families.\n<\/p>\n<p>\n<b>About Specialty Alliance<\/b>\n<\/p>\n<p>\nSpecialty Alliance is a multi-specialty management services organization supporting physician practices across the country. Its platform spans gastroenterology, urology, radiation oncology, and other specialties, providing clinical, operational, and administrative services that empower providers to deliver high-quality care.\n<\/p>\n<p>\n<i>OM Partners, LLC served as exclusive financial advisor, and Sherrard, German &amp; Kelly, PC served as legal counsel to Cosan. Reed Smith LLP served as legal counsel to Ziegler Link-age Funds. Ropes &amp; Gray LLP served as legal counsel to GI Alliance.&#8221;<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact:<\/b><br \/>David Hunt<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;&#x3a;&#x44;a&#x76;&#105;&#x64;&#46;&#x48;&#117;n&#x74;&#64;&#x63;&#111;&#x73;&#97;n&#x67;&#114;&#x6f;&#117;&#x70;&#46;c&#x6f;m\" rel=\"nofollow\" shape=\"rect\">&#68;&#x61;v&#105;&#x64;&#46;&#72;&#x75;n&#116;&#x40;c&#111;&#x73;a&#110;&#x67;r&#111;&#x75;p&#46;&#x63;o&#109;<\/a><br \/>508.397.7636\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cosan, a connected chronic care management company helping providers extend care beyond the clinic, today announced a $15 million strategic growth equity investment led by Ziegler Link-age Funds and Specialty Alliance, the nation\u2019s largest provider of specialty care and a long-standing Cosan partner. The investment accelerates Cosan\u2019s expansion of its AI-enabled, human-led virtual care &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62375","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cosan, a connected chronic care management company helping providers extend care beyond the clinic, today announced a $15 million strategic growth equity investment led by Ziegler Link-age Funds and Specialty Alliance, the nation\u2019s largest provider of specialty care and a long-standing Cosan partner. The investment accelerates Cosan\u2019s expansion of its AI-enabled, human-led virtual care ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-17T21:05:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/22\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions\",\"datePublished\":\"2025-12-17T21:05:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/\"},\"wordCount\":513,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251216259408\\\/en\\\/2672343\\\/22\\\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/\",\"name\":\"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251216259408\\\/en\\\/2672343\\\/22\\\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\",\"datePublished\":\"2025-12-17T21:05:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251216259408\\\/en\\\/2672343\\\/22\\\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251216259408\\\/en\\\/2672343\\\/22\\\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/","og_locale":"en_US","og_type":"article","og_title":"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions - Pharma Trend","og_description":"CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cosan, a connected chronic care management company helping providers extend care beyond the clinic, today announced a $15 million strategic growth equity investment led by Ziegler Link-age Funds and Specialty Alliance, the nation\u2019s largest provider of specialty care and a long-standing Cosan partner. The investment accelerates Cosan\u2019s expansion of its AI-enabled, human-led virtual care ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-17T21:05:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/22\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions","datePublished":"2025-12-17T21:05:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/"},"wordCount":513,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/22\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/","url":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/","name":"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/22\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg","datePublished":"2025-12-17T21:05:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/22\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251216259408\/en\/2672343\/22\/0a16b85e-9c2d-4610-ad68-4896a6422758-Cosan_Green_New_March_2024.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cosan-secures-strategic-growth-investment-to-scale-ai-enabled-team-based-virtual-care-for-chronic-conditions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62375"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62375\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}